MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Preserved white matter microstructure in Parkinson’s disease patients with levodopa-induced dyskinesia: Evaluation by neurite orientation dispersion and density imaging (NODDI)

    T. Ogawa, T. Hatano, H. Takeshige, C. Andica, K. Kamagata, A. Saito, T. Koinuma, R. Nakamura, H. Iwamuro, G. Oyama, Y. Shimo, A. Umemura, M. Ito, S. Aoki, N. Hattori (Tokyo, Japan)

    Objective: Brain microstructure alteration using MRI in Parkinson's disease (PD) have not been well studied. We analysis the white matter alterations in Parkinson’s disease with…
  • 2019 International Congress

    Neuroradiological differences between patients with akinesia-dominant and tremor-dominant Parkinson’s disease

    KO. Ohta, TN. Nakajima (Kashiwazaki, Japan)

    Objective: To compare the metabolism of the putamen and the cerebral cortex between the akinesia-dominant group and the tremor-dominant group of Parkinson's disease (PD) patients.…
  • 2019 International Congress

    Probing Error Signals of Postural Control in Fragile X Premutation carriers

    C. O'Keeffe, M. Carro Domínguez, E. O'Rourke, N. Feerick, T. Lynch, R. Reilly (Dublin, Ireland)

    Objective: This study aimed to characterize cortical theta activity in Fragile X Premutation carriers during continuous balance. Background: Fragile X Associated Tremor/Ataxia Syndrome (FXTAS) is…
  • 2019 International Congress

    Structural connectivity changes in G2019S-LRRK2 gene mutation carriers without manifest Parkinson’s disease

    G. Pagano, P. Vickers, J. Schulz, H. Wilson, M. Politis (London, United Kingdom)

    Objective: We hypothesised that abnormal sprouting of serotonergic terminals in the hypothalamus may lead to abnormal structural connectivity, which can be measured with diffusion tensor…
  • 2019 International Congress

    Mitochondrial Complex 1, Sigma 1 Receptor and Synaptic Vesicle protein 2A density in early de novo patients with Parkinson’s Disease: pilot PET data

    G. Pagano, H. Wilson, A. Mansur, S. Caminiti, R. Comley, H. Tsukada, R. Gunn, E. Rabiner, M. Politis (London, United Kingdom)

    Objective: In this study, we evaluated the density of Mitochondrial complex 1 (MC1), sigma 1 receptor (s1R) and Synaptic Vesicle protein 2A (SV2A) in early…
  • 2019 International Congress

    Comparison of PDE10A and DAT expression as markers of disease burden in early Parkinson’s disease

    G. Pagano, H. Wilson, T. Yousaf, F. Niccolini, N. Khan, D. Martino, R. Gunn, E. Rabiner, P. Piccini, T. Foltynie, M. Politis (London, United Kingdom)

    Objective: We aimed to compare loss of PDE10A and DAT expression in patients with Parkinson’s disease. Background: Recent work has shown loss of PDE10A expression…
  • 2019 International Congress

    Age-related failure in compensatory mechanisms and its relation to the Parkinson phenotype: evidence from a SPECT study in early and late-onset PD

    G. Palermo, D. Frosini, S. Giannoni, M. Giuntini, D. Volterrani, U. Bonuccelli, R. Ceravolo (Pisa, Italy)

    Objective: To investigate if a less prominent dopaminergic dysfunction on 123I-ioflupane SPECT imaging (DaTSCAN) despite a more severe motor phenotype in Late Onset Parkinson’s Disease…
  • 2019 International Congress

    Structural imaging changes in hepatic and neurological Wilson disease

    A. Patel, K. Nalamada, A. Vives-Rodriguez, D. Robakis, T. Constable, J. Arora, M. Schilsky, S. Tinaz (New Haven, CT, USA)

    Objective: To quantitatively assess cerebral structural changes in Wilson disease (WD) subjects with hepatic and neurological phenotypes. Background: WD is a rare autosomal recessive disorder…
  • 2019 International Congress

    Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT study

    A. Pilotto, F. Schianodicola, E. Premi, R. Grasso, R. Turrone, S. Gipponi, A. Scalvini, E. Cottini, B. Pagherà, V. Garibotto, MC. Rizzetti, L. Bonanni, B. Borroni, S. Morbelli, F. Nobili, UP. Guerra, D. Perani, A. Padovani (Brescia, Italy)

    Objective: To evaluate the common and divergent dopaminergic and serotonergic impairment in Parkinson's disease and dementia with Lewy bodies using 123I-FP-CIT imaging. Background: Striatal dopaminergic…
  • 2019 International Congress

    Different patterns of brain activity during lower limb movements in Parkinson’s disease patients with and without freezing of gait

    N. Piramide, E. Sarasso, E. Canu, S. Galantucci, A. Tettamanti, MA. Volontè, M. Filippi, F. Agosta (Milan, Italy)

    Objective: To assess brain functional MRI (fMRI) activity during a feet movement task in Parkinson’s disease patients with (PD-FoG) and without freezing of gait (PD-noFoG)…
  • « Previous Page
  • 1
  • …
  • 1397
  • 1398
  • 1399
  • 1400
  • 1401
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley